Advertise
Resources
Member, Beacon International Group, Ltd.
The U.S. Supreme Court could rule as soon as April 14 in the legal battle over abortion pills – and could effectively override the Food and Drug Administration's decision-making if it doesn't turn back a ruling limiting the use of the drug mifepristone, Axios reports. Until last week, such a sweeping blow against the FDA's authority would have been unprecedented. Now it's a real possibility – one that could quickly threaten access to the pill used in more than half of U.S. abortions.